ONCY MEXC RealStocks
Own real ONCY shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 07:45:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Oncolytics Biotech, Inc. (ONCY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.44, with a market capitalization of $52.07M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.33 to $1.30. This page covers its latest market performance, valuation, price trends and company information.
$52.07M | |
$0.39 | |
$0.44 | |
$0.38 | |
$0.38 | |
1.91M | |
1.16M | |
-- | |
$1.30 | |
$0.33 | |
-- | |
2026-06-30 |
Oncolytics Biotech, Inc. (ONCY) last closed at $0.44 as of 2026-11-19 00:57:00, up 12.68% ($0.05) from the previous close of $0.38.
During the latest regular trading session, ONCY traded between $0.38 and $0.44, with a volume of 1.91M shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, Oncolytics Biotech, Inc. (ONCY) moved from $0.38 to $0.44, representing a gain of 14.72% ($0.06).
The stock traded between $0.33 and $0.45 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1.32 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 10.8%
ONCY is currently trading at $0.44, placing it 10.8% of the way from its 52-week low of $0.33 to its 52-week high of $1.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 29 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Oncolytics Biotech, Inc. (ONCY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ONCY, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ONCY shares and USD.
ONCY Shares to USD
1.00 ONCY shares = 0.438 USD
Calculations are estimates based on the latest available price and are for reference only.